Human Tissue Engineered Model of Myocardial Ischemia-Reperfusion Injury
Timely reperfusion after a myocardial infarction is necessary to salvage the ischemic region; however, reperfusion itself is a major contributor to the final tissue damage. Currently, there is no clinically relevant therapy available to reduce ischemia-reperfusion injury. While many drugs have shown...
| Main Author: | |
|---|---|
| Language: | English |
| Published: |
2018
|
| Subjects: | |
| Online Access: | https://doi.org/10.7916/D8087P0Q |